Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Rheumatology. Supplement|June 11, 2009
Assessment and management of rheumatoid arthritisBoulos HaraouiSeminars in Arthritis and Rheumatism|April 27, 2005
Differentiating the efficacy of the tumor necrosis factor inhibitorsBoulos HaraouiThe Journal of Rheumatology. Supplement|March 3, 2005
Differentiating the efficacy of tumor necrosis factor inhibitorsBoulos HaraouiThe Journal of Rheumatology. Supplement|January 22, 2005
The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritisBoulos HaraouiNature Reviews. Rheumatology|April 14, 2010
To switch or to change class-the biologic dilemma in rheumatoid arthritisEdith Villeneuve, Boulos HaraouiThe Journal of Rheumatology|May 4, 2010
Predictors of clinical response and radiographic progression in patients with rheumatoid arthritis treated with methotrexate monotherapyJulie Drouin, Boulos Haraoui, Seminars in Arthritis and Rheumatism|February 8, 2011
Treatment of early rheumatoid arthritis: concepts in managementBoulos Haraoui, Janet PopeRheumatic Diseases Clinics of North America|June 3, 2004
Adalimumab therapy in rheumatoid arthritisEdward Keystone, Boulos HaraouiSeminars in Arthritis and Rheumatism|August 19, 2008
Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of actionBoulos Haraoui, Marilyn KrelenbaumCurrent Opinion in Rheumatology|December 14, 2005
Musculoskeletal manifestations and autoimmune diseases related to new biologic agentsBoulos Haraoui, Edward KeystonePageof 14